Eliane Markowitz - BIO VIEW External Director

  Director
Dr. Eliane Markowitz was appointed External Director at BioView Ltd effective June 1, 2015
Age: 50  Director Since 2015  Ph.D    
972 73 227 1025  http://www.bioview.com
Markowitz work experience includes the following roles: Director at Teva Medical from 2014, Chief Executive Officer at Abbott Diagnostics between 2010 and 2014 and Vice President at Medison between 2005 and 2010. She holds a Doctorate of Science degree in Animal Science.

BIO VIEW Management Efficiency

BIO VIEW has return on total asset (ROA) of (3.69) % which means that it has lost $3.69 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (6.08) %, meaning that it generated substantial loss on money invested by shareholders. BIO VIEW management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 2.57 M in total debt with debt to equity ratio (D/E) of 11.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. BIO VIEW has a current ratio of 2.1, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist BIO VIEW until it has trouble settling it off, either with new capital or with free cash flow. So, BIO VIEW's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BIO VIEW sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BIO VIEW to invest in growth at high rates of return. When we think about BIO VIEW's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing few of many executives

DIRECTOR Since

Liat BinyaminiE SCHNAPP WORKS
2011
Orly ZilbermanREKAH PHARMA IND
2015
Bracha PolskyLitvakISROTEL LTD
2016
Itiel EfratMAGIC SOFTWARE ENT
2006
Ehood NisanREKAH PHARMA IND
2016
Ishay DavidiREKAH PHARMA IND
2015
Liat BenyaminiE SCHNAPP WORKS
2011
Arnon ZuaretzREKAH PHARMA IND
2016
Naamit SalomonMAGIC SOFTWARE ENT
2003
Yehezkel ZeiraMAGIC SOFTWARE ENT
2005
Moshe MagidISROTEL LTD
1992
David KirkISROTEL LTD
2016
Ifat ZakE SCHNAPP WORKS
2016
Nurit NahumISROTEL LTD
2019
Simon LouisISROTEL LTD
2005
Avi PrestmanE SCHNAPP WORKS
2009
Elan PennMAGIC SOFTWARE ENT
2005
Ilan HoreshREKAH PHARMA IND
2007
Jacob GoldmanISROTEL LTD
2007
Nahum KaraISROTEL LTD
2008
Itzhak ArbelE SCHNAPP WORKS
2011
BioView Ltd. develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company was founded in 2000 and is headquartered in Rehovot, Israel. BIO VIEW is traded on Tel Aviv Stock Exchange in Israel. BIO VIEW (BIOV) is traded on Tel Aviv Stock Exchange in Israel and employs 12 people.

BIO VIEW Leadership Team

Elected by the shareholders, the BIO VIEW's board of directors comprises two types of representatives: BIO VIEW inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BIO VIEW. The board's role is to monitor BIO VIEW's management team and ensure that shareholders' interests are well served. BIO VIEW's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BIO VIEW's outside directors are responsible for providing unbiased perspectives on the board's policies.
Elad Kfir, Vice President of Marketing
Eliane Markowitz, External Director
Yuval Harari, Co-CEO, Director
Emmanuel Gill, Chairman of the Board
David Kutas, CEO of BioView Inc - USA and President of BioView Inc - USA
Yacha Sutton, Director
Marina Wolfson, CFO
Alan Schwebel, CEO and Pres
Jackie RosenblumGoren, External Director
Inbal Hillel, Vice President - Operations
Lior Shav, Director
Eliyahu AyalonLanciano, External Director
Warren Esanu, Director

BIO VIEW Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BIO VIEW a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in BIO VIEW without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run CEO Directory Now

   

CEO Directory

Screen CEOs from public companies around the world
All  Next Launch Module

Pair Trading with BIO VIEW

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BIO VIEW position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BIO VIEW will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Twitter could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Twitter when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Twitter - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Twitter to buy it.
The correlation of Twitter is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Twitter moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Twitter moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Twitter can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities. You can also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Tools for BIO VIEW Stock

When running BIO VIEW price analysis, check to measure BIO VIEW's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO VIEW is operating at the current time. Most of BIO VIEW's value examination focuses on studying past and present price action to predict the probability of BIO VIEW's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BIO VIEW's price. Additionally, you may evaluate how the addition of BIO VIEW to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go